Legal & General Group Plc decreased its holdings in shares of Waystar Holding Corp. (NASDAQ:WAY – Free Report) by 11.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 270,414 shares of the company’s stock after selling 34,702 shares during the quarter. Legal & General Group Plc owned about 0.14% of Waystar worth $8,856,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of WAY. Royal Bank of Canada raised its stake in Waystar by 11.3% during the first quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after purchasing an additional 2,195 shares in the last quarter. AQR Capital Management LLC purchased a new stake in Waystar during the first quarter valued at $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Waystar by 91.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after purchasing an additional 22,364 shares in the last quarter. NewEdge Advisors LLC purchased a new stake in Waystar during the first quarter valued at $234,000. Finally, Goldman Sachs Group Inc. raised its stake in Waystar by 13.4% during the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock valued at $27,918,000 after purchasing an additional 88,256 shares in the last quarter.
Waystar Trading Up 3.6%
Shares of WAY opened at $20.22 on Friday. Waystar Holding Corp. has a twelve month low of $17.89 and a twelve month high of $41.49. The company has a market cap of $3.88 billion, a P/E ratio of 30.18, a P/E/G ratio of 0.77 and a beta of 0.10. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37. The company’s fifty day simple moving average is $22.07 and its 200-day simple moving average is $26.82.
Wall Street Analyst Weigh In
WAY has been the topic of a number of recent research reports. Bank of America decreased their price target on shares of Waystar from $45.00 to $38.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. JPMorgan Chase & Co. decreased their price target on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. Loop Capital set a $33.00 price target on shares of Waystar in a research note on Wednesday, February 18th. Wells Fargo & Company reduced their target price on shares of Waystar from $41.00 to $36.00 and set an “overweight” rating on the stock in a research note on Thursday, February 19th. Finally, Raymond James Financial reissued a “strong-buy” rating and issued a $32.00 target price on shares of Waystar in a research note on Thursday, April 30th. Three investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average price target of $35.62.
View Our Latest Research Report on WAY
Waystar Profile
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
Recommended Stories
- Five stocks we like better than Waystar
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
